Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
1910
AddedFeb 17, 2024
UpdatedJul 3, 2026
1910

1910

Pre-Seed

AI-driven biotech firm speeding up drug design for various diseases.

HQ
Cambridge, MA, US
Founded
2018
Accelerator
Y Combinator logoY CombinatorW19
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to revolutionize drug development, 1910 Genetics integrates AI, computation, and biological automation to design small molecule and protein therapeutics. The company aims to reduce the time and cost associated with drug development while increasing the success rate of bringing innovative medicines to patients. Their proprietary drug discovery engines, ELVIS™ and ROSALYND™, enable the design of both small molecule and protein therapeutics, making them a unique player in the AI-driven biotech space.

Notable figures affiliated with 1910 Genetics include its leadership team and key investors from leading pharmaceutical and technology sectors. The company has achieved significant milestones, including the development of a multimodal AI platform that combines computational data with wet lab biological data. This has positioned 1910 Genetics as a critical partner for leading pharma and tech companies, enhancing their drug discovery capabilities and advancing their internal pipeline, particularly in neurological diseases.

1910 - Similar Companies

GEn1E Lifesciences logo

GEn1E Lifesciences

gen1e.com

Verge Genomics logo

Verge Genomics

vergegenomics.com

WhiteLab Genomics logo

WhiteLab Genomics

whitelabgx.com

NeuroX1 logo

NeuroX1

neurox1.com

Insitro logo

Insitro

insitro.com

Probably Genetic logo

Probably Genetic

Harmonic Discovery logo

Harmonic Discovery

Generate Biomedicines logo

Generate Biomedicines

Anagenex logo

Anagenex

anagenex.com

Diffuse Bio logo

Diffuse Bio

diffuse.bio

PostEra logo

PostEra

postera.ai

Sequence Bio logo

Sequence Bio

sequencebio.com

GeneCentrix logo

GeneCentrix

genecentrix.com

DeepCure logo

DeepCure

deepcure.ai

Cognaisent logo

Cognaisent

cognaisent.com

1910 - Quick Facts

Who are 1910's competitors?

Companies similar to 1910 include GEn1E Lifesciences, Verge Genomics, WhiteLab Genomics and NeuroX1.

When was 1910 founded?

1910 was founded in 2018.

Where is 1910's headquarters located?

1910's headquarters is located in Cambridge, MA, US.

When was 1910's last funding round?

1910's most recent funding round was for $550k (USD) in September 2021.

How much has 1910 raised to-date?

As of Sep 30, 2021, 1910 has raised a total of $26.8M (USD).

How many employees does 1910 have?

1910 has 22 employees as of Feb 5, 2024.

1910 - Classification

Ownership
  • Private Equity
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Discovery
Tags
  • AI Operations
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541500Computer Systems Design and Related Services
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 513210Software Publishers
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 8000Health Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7371Computer Programming Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified